Treatment and warning of recurring therapy and other events using an implantable device
View Patent ↗An implantable neurostimulator system is capable of responsively treating epileptiform activity with electrical stimulation and other therapies and is further configured to detect periods of increased susceptibility to clinical seizures. The event densities of therapy applications (or detections or other events) in time are observed and calculated, and if high enough, measures are taken to warn the patient or provide additional therapy.
1. An implantable device for detecting a patient's increased susceptibility to neurological events and triggering an action when a state of increased susceptibility is detected, the device comprising:
a central processing unit provided with a therapy density analyzer, the therapy density analyzer further comprising:
a therapy counter configured to count as a therapy event each time a therapy is delivered to the patient and to compare the number of therapy events to a predetermined number of therapy events;
an interval counter configured to measure, if the number of therapy events reaches the predetermined number of therapy events, the time elapsed from the first counted therapy event up to the predetermined number of therapy events; and
a density evaluator configured to compare the time elapsed from the first counted therapy event up to the predetermined number of therapy events to a predetermined time interval, and if elapsed time is less than the predetermined time interval, to provide a signal that is configured to initiate one or more actions to respond to the neurological events.
2. The implantable device of claim 1 , wherein each of the therapy events represents an application of a responsive electrical stimulation therapy.
3. An event density analyzer for a closed-loop neurostimulator device which device is configured to deliver predetermined therapies to a patient in response to predetermined conditions in an EEG signal that are sensed by the device and that are associated with a neurological disorder, the event density analyzer comprising:
an event counter configured to count as an event each time a predetermined therapy is delivered and to compare the number of events to a predetermined number of events, N;
an interval counter configured to measure, if the number of events reaches the predetermined number of events, N, the time elapsed between the first counted event and the Nth counted event;
a density evaluator configured to compare the time elapsed between the first counted event and the Nth counted event to a predetermined time interval, and if the time elapsed is less than the predetermined time interval, to provide a signal that is configured adapted to initiate one or more actions by the neurostimulator device wherein the one or more actions are configured to respond to the neurological disorder.
4. The event density analyzer of claim 3 , wherein the one or more actions are selected from the group consisting of: alerting the patient using an audio transducer directly or indirectly in communication with the event density analyzer; alerting the patient using a somatosensory transducer directly or indirectly in communication with the event density analyzer; alerting the patient using telemetry associated with the event density analyzer and in operable communication with a patient alerting device; and alerting a patient's caregiver using telemetry associated with the event density analyzer and in operable communication with a caregiver's alerting device.
5. The event density analyzer of claim 3 , wherein the one or more actions comprise sending one or more signals that will cause the closed-loop neurostimulator to change the therapy it delivers in response to the predetermined conditions.
6. The event density analyzer of claim 5 , wherein changing the therapy comprises changing the form of therapy from a form of pulsatile electrical stimulation to a form of nonpulsatile stimulation.
7. The event density analyzer of claim 6 , wherein the nonpulsatile stimulation is sine wave stimulation.
8. The event density analyzer of claim 5 , wherein changing the therapy comprises changing the form of therapy from a form of electrical stimulation to a drug therapy.
9. A method of determining when a patient's brain activity corresponds to activity that is particularly susceptible to seizure activity comprising:
counting as an event in an event counter associated with a neurostimulator each instance of delivery of a first predetermined therapy by a neurostimulator to a patient, where the first predetermined therapy is configured to terminate seizures, seizure onsets or precursors of seizures;
if the count of events reaches a predetermined count of events, measuring with an interval counter the time interval between the first event and the predetermined count of events and comparing the measured time interval to a predetermined time interval;
if the measured time interval is less than the predetermined time interval, reconfiguring the neurostimulator to deliver a second predetermined therapy, where the second predetermined therapy is different from the first predetermined therapy and the second predetermined therapy is configured to counteract the activity.